Omicron-specific booster might not be wanted, US monkey research finds

[CHICAGO] A research in monkeys pitting the present Moderna Covid-19 booster in opposition to an Omicron-specific booster confirmed no important variations in safety, suggesting an Omicron-specific booster might not be wanted, US authorities researchers reported on Friday (Feb 4).

The research concerned monkeys vaccinated with 2 doses of Moderna’s vaccine who had been dosed 9 months later with both the traditional Moderna booster or one particularly focusing on the Omicron variant.

The researchers examined varied features of the animals’ immune responses and uncovered them to the virus. They discovered each boosters produced “comparable and important will increase in neutralising antibody responses” in opposition to the entire variants of concern, together with Omicron, in keeping with the research, posted on bioRxiv forward of peer overview.

Each Moderna and BioNTech/Pfizer have began testing Omicron-specific boosters of their vaccines in human medical trials.

“That is very, superb information,” Daniel Douek, a vaccine researcher on the Nationwide Institute of Allergy and Infectious Ailments who co-lead the research, stated in a phone interview.

“It means we need not radically redesign the vaccine to make it an Omicron vaccine.”

Douek stated he believes the reason being that each the unique and the Omicron-specific vaccines are “cross-reactive”, which means they will recognise a number of completely different variants.

The outcomes are just like research testing a Moderna booster focusing on the Beta variant, stated John Moore, a professor of microbiology and immunology at Weill Cornell Medical School who was not concerned within the research.

“Let’s have a look at what the human information present,” Moore stated. “Monkey information are usually fairly predictive, however you’ll want the human information.”

One key benefit of the monkey research is that researchers can enhance the animals after which infect them with the virus and measure the immune response, one thing that would not be accomplished in human trials, Moore stated. REUTERS